What is the diagnosis and treatment for eclampsia (a severe complication of preeclampsia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Eclampsia requires immediate treatment with magnesium sulfate as the first-line anticonvulsant therapy, with a standard loading dose of 4-6g IV over 15-20 minutes, followed by a maintenance infusion of 1-2g per hour, as recommended by the most recent guidelines 1.

Treatment Overview

The treatment of eclampsia involves several key components, including:

  • Magnesium sulfate administration to prevent seizures and manage eclampsia
  • Blood pressure control using medications like labetalol or hydralazine to maintain systolic pressure below 160mmHg and diastolic below 110mmHg
  • Definitive treatment with delivery of the baby, which should be expedited once the mother is stabilized
  • Close monitoring of the patient's respiratory rate, deep tendon reflexes, and urine output, with magnesium levels checked periodically

Blood Pressure Management

Blood pressure control is essential in the management of eclampsia, with the goal of maintaining systolic pressure below 160mmHg and diastolic below 110mmHg. Medications like labetalol (20-80mg IV every 10-30 minutes) or hydralazine (5-10mg IV every 20-30 minutes) can be used to achieve this goal, as recommended by recent guidelines 1.

Delivery

Definitive treatment for eclampsia is delivery of the baby, which should be expedited once the mother is stabilized. The decision to deliver should be based on the gestational age of the fetus, the severity of the mother's condition, and the presence of any complications, as outlined in recent guidelines 1.

Additional Considerations

Additional considerations in the management of eclampsia include:

  • Close monitoring of the patient's condition, including respiratory rate, deep tendon reflexes, and urine output
  • Magnesium levels should be checked periodically to avoid toxicity
  • If seizures persist despite magnesium therapy, additional anticonvulsants like diazepam (5-10mg IV) or lorazepam (2-4mg IV) may be necessary
  • The condition results from severe vasospasm and endothelial damage affecting multiple organ systems, particularly the brain, and requires prompt and effective treatment to prevent maternal and fetal morbidity and mortality, as highlighted in recent studies 1.

From the FDA Drug Label

In Pre-eclampsia or Eclampsia In severe pre-eclampsia or eclampsia, the total initial dose is 10 to 14 g of magnesium sulfate. Intravenously, a dose of 4 to 5 g in 250 mL of 5% Dextrose Injection, USP or 0. 9% Sodium Chloride Injection, USP may be infused. Simultaneously, IM doses of up to 10 g (5 g or 10 mL of the undiluted 50% solution in each buttock) are given Alternatively, the initial IV dose of 4 g may be given by diluting the 50% solution to a 10 or 20% concentration; the diluted fluid (40 mL of a 10% solution or 20 mL of a 20% solution) may then be injected IV over a period of three to four minutes Subsequently, 4 to 5 g (8 to 10 mL of the 50% solution) are injected IM into alternate buttocks every four hours as needed, depending on the continuing presence of the patellar reflex and adequate respiratory function. Alternatively, after the initial IV dose, some clinicians administer 1 to 2 g/hour by constant IV infusion. Therapy should continue until paroxysms cease A serum magnesium level of 6 mg/100 mL is considered optimal for control of seizures. A total daily (24 hr) dose of 30 to 40 g should not be exceeded.

The treatment for eclampsia involves administering magnesium sulfate with a total initial dose of 10 to 14 g.

  • The initial dose can be given intravenously as 4 to 5 g in 250 mL of 5% Dextrose Injection, USP or 0.9% Sodium Chloride Injection, USP.
  • Alternatively, the initial IV dose of 4 g may be given by diluting the 50% solution to a 10 or 20% concentration.
  • IM doses of up to 10 g can be given simultaneously.
  • Subsequent doses of 4 to 5 g can be injected IM into alternate buttocks every four hours as needed.
  • The therapy should continue until paroxysms cease and a serum magnesium level of 6 mg/100 mL is considered optimal for control of seizures 2.
  • A total daily dose of 30 to 40 g should not be exceeded.

From the Research

Definition and Treatment of Eclampsia

  • Eclampsia is a life-threatening complication of pregnancy, characterized by the occurrence of seizures in association with pre-eclampsia 3.
  • Magnesium sulfate is the drug of choice for preventing and treating eclampsia, as it has been shown to more than halve the risk of eclampsia 4.
  • The use of magnesium sulfate has been compared to other anticonvulsants, such as phenytoin and nimodipine, and has been found to be more effective in reducing the risk of eclampsia 4.

Administration of Magnesium Sulfate

  • The administration of magnesium sulfate can be done through intravenous infusion, with a loading dose of 4-6 grams, followed by a maintenance dose of 1-2 grams per hour 5, 6.
  • The optimal maintenance dose of magnesium sulfate is still a topic of debate, with some studies suggesting that a dose of 1 gram per hour is as effective as a dose of 2 grams per hour, with fewer side effects 5.
  • The use of magnesium sulfate has been shown to reduce the risk of placental abruption and increase the risk of caesarean section 4.

Side Effects and Complications

  • The use of magnesium sulfate can cause side effects, such as flushing, and complications, such as oliguria and postpartum hemorrhage 5, 6.
  • The risk of side effects and complications can be minimized by careful monitoring of serum magnesium levels and adjustment of the dose as needed 5.
  • The use of magnesium sulfate has been shown to have no clear effect on outcome after discharge from hospital, but it may reduce maternal death 4.

Prevention and Management of Eclampsia

  • The prevention and management of eclampsia require timely blood pressure assessment and administration of magnesium sulfate 3.
  • The use of alternative antihypertensive agents, such as labetalol and hydralazine, may provide additional benefit in the management of hypertension for preeclamptic patients 7.
  • The diagnosis of preeclampsia beyond the gestation period of 38 weeks requires delivery, and the presence of maternal compromise or eclampsia at gestation greater than 20 weeks also necessitates delivery 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

The Cochrane database of systematic reviews, 2010

Research

Magnesium sulphate in the prophylaxis and treatment of eclampsia.

Journal of Ayub Medical College, Abbottabad : JAMC, 2004

Research

Pharmacotherapeutic options for the treatment of preeclampsia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.